期刊文献+

高血压病的基因治疗 被引量:1

暂未订购
导出
作者 陈奎
出处 《淮海医药》 CAS 2008年第6期570-572,共3页 Journal of Huaihai Medicine
  • 相关文献

参考文献20

  • 1江其生,王升启.基因治疗高血压的研究进展[J].国外医学(药学分册),2003,30(2):83-86. 被引量:5
  • 2M.Sean McMurtry,Stephen L.Archer,Dario C.Altieri,Sebastien Bonnet,Alois Haromy,Gwyneth Harry,Sandra Bonnet,Lakshmi Puttagunta,and Evangelos D.Michelakis.Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension[J].Clin Invest,2005(June),115(6):1479-1491.
  • 3Kate L.Dishart,Lorraine M.Work,Laura Denby,and Andrew H.Barker Gene Therapy for cardiovascular disease[J].Biomed Biotechnol,2003,2003(2):138-148.
  • 4杨华英.高血压病基因治疗临床前研究近况[J].实用心脑肺血管病杂志,2002,10(3):165-169. 被引量:2
  • 5C Wang,L Chao,and J Chao Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats[J].Clin Invest,1995(April),95(4):1710-1716.
  • 6JA Martinez and D T O'connor.Somatic cell gene therapy for a trait as complex as hypertension[J].Clin Invest,1995(April),95(4):1426.
  • 7Neil A Holtzman and David Shapiro.The new genetics:Genetic testing and public policy[J].1998(March),14,316(7134):852-856.
  • 8Brian S.Zuckerbraun,Beek Yoke Chin,Barbara Wegiel,Timothy R.Billiar,Eva Czsimadia,Jayashree Rao,Larissa Shimoda,Emeka Ifedigbo,Shin Kanno,and Leo E.Carbon monoxide reverses established pulmonary hypertension[J].Exp Med,2006,September 4;203(9):2109-2119.
  • 9Hilal Al Sabti.Therapeutic angiogenesis in cardiovascular disease[J].Cardiothorac Surg,2007,249.Publisched online,2007 November 16.
  • 10Phillips MI,Mohuczy-Dominiak D,Coffey M,et al.Prolonged reduction of high blood pressure with an invivo,nonpathogenic adeno-associated viral vector delivery of AT1RmRNA antisense[J].Hypertension,1997,29(1 Pt2):374-380.

二级参考文献83

  • 1吴锡桂.高血压的发病率与人群分布[A].刘力生.高血压[C].北京:人民卫生出版社,2001.5-13.
  • 2[1]Fyhrquist F,Metsarinne K,Tikkanen I.Role of angiotensin Ⅱ in blood pressure regulation and in the pathophysiology of cardiovascular disorders[J].J Hum Hypertens,1995,9(Suppl 5):S19-S24.
  • 3[2]Hall JE,Brands MW,Henegar JR.Angiotensin Ⅱ and longterm arterial pressure regulation:the overriding dominance of the kidney[J].Am Soc Nephrol,1999,10(Suppl 12):S258-S265.
  • 4[3]Phillips MI.Is gene therapy for hypertension possible[J].Hypertension,1999,33(1):8-13.
  • 5[4]Giles RV,Ruddell CJ,Spiller DG,et al.Single base discrimination for ribonuclease Hdependent antisense effects within intact human leukemia cells[J].Nucleic Acids Res,1995,23 (6):954-961.
  • 6[5]Phillips MI,Mahuczy-Dominiak D,Coffey M,et al.Prolonged reduction of high blood pressure with an in vivo,nonpathogenic,adenoassociated viral vector delivery of AT1R Mrna antisense[J].Hypertension,1997,29 (1 Pt 2):374-380.
  • 7[6]Gelband CH,Reaves PY,Dang H,et al.Reversal of hyper tension by retroviral-mediated (LNSV) delivery of angiotensin Ⅱ type 1 receptor antisense (AT1R-AS) in the adult spontaneously hypertensive rat (SHR)[J].Circulation,1998,98(Suppl):I320.
  • 8[7]Gelband,CH,Reaves PY,Evans J,et al.Angiotensin Ⅱ type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension[J].Hyperten sion,1999,33(1 Pt 2):360-365.
  • 9[8]Iyer SN,Lu D,Katovich MJ,et al.Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense[J].Proc Natl Acad Sci U S A,1996,93(18):9960-9965.
  • 10[9]Phillips MI,Kimura B.Gene therapy for hypertension:antisense inhibition of the renin-angiotensin system[J].Methods Mol Med,2005,108:363-379.

共引文献8

同被引文献8

  • 1Mancia G,de Backer G,Dominiczak A,et al.2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)[].Journal of Hypertension.2007
  • 2Khan,N.A.,Hemmelgarn,B.,Padwal,R.Canadian Hypertension Education Program: the 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2—therapy[].Canadian Journal of Cardiology.2007
  • 3Chapman,N.,Dobson,J.,Wilson,S.Effect of spironolactone on blood pressure in subjects with resistant hypertension[].Journal of Hypertension.2007
  • 4Lane,D.A.,Shah,S.,Beevers,D.G.Low-dose spironolactone in the management of resistant hypertension: a surveillance study[].Journal of Hypertension.2007
  • 5Pratt-Ubunama MN,Nishizaka MK,Boedefeld RL,et al.Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension[].Chest.2007
  • 6Weir MR.Renin inhibitors:novel agents for renoprotection or a better angiotensin receptor blocker for blood pressure lowering[J]?[].Current Opinion in Nephrology and Hypertension.2007
  • 7Tsai PS,Chang NC,Chang WY,et al.Blood pressure biofeedback exert intermediate-term effects on blood pressure and pressure reactivity in individuals with mild hypertension:a randomized controlled study[].Journal of Alternative and Complementary Medicine.2007
  • 8杨利婷,赵景波.高血压相关基因研究进展[J].中国公共卫生,2009,25(1):18-20. 被引量:8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部